If scientists will soon be decoding entire human genomes in an afternoon, for $1,000 or less, how will that change the way we think about health and wellness? What are the business opportunities for companies that figure this out early? How will tech companies handle the gargantuan IT challenges of separating signal from the noise in the billions of genomic data points on each of us?
Can you tell I’m starting to get fired up about Xconomy Seattle’s next big event, “Computing in the Age of the $1,000 Genome?” We are less than two weeks away from this rare assembly of West Coast infotech and biotech talent, which will be held the afternoon of February 7th at the Pinard Auditorium at Swedish Medical Center’s Cherry Hill Campus. A few tickets are left for this gathering, but it is on track to sell out in advance. Even though the speakers are primarily from Seattle and San Francisco, we have had a few prominent attendees say they are flying in from around the country for this gathering.
As a reminder, here’s the lineup of speakers.
—Leroy Hood, the co-founder and president of the Institute for Systems Biology, Seattle
—Cliff Reid, co-founder and CEO, Mountain View, CA-based Complete Genomics
—Eric Schadt, chief scientific officer, Menlo Park, CA-based Pacific Biosciences
—Jim Karkanias, senior director, applied research and technology, Microsoft Health Solutions, Redmond, WA
—Deepak Singh, senior business development manager, Amazon Web Services, Seattle
—Rowan Chapman, partner, Menlo Park, CA-based Mohr Davidow Ventures
—Andreas Sundquist, co-founder and CEO, Palo Alto, CA-based DNANexus
—Ilya Kupershmidt, co-founder and VP of products, Cupertino, CA-based NextBio
—Rob Arnold, president, Seattle-based Geospiza
—Tim Hunkapiller, Seattle-based consultant, Life Technologies
—Paul Rutherford, chief technology officer, Isilon Storage Division, EMC, Seattle
—Bob Nelsen, managing director, Arch Venture Partners, Seattle
So if you haven’t already, register here mark your calendars for the afternoon of February 7 for some thoughtful conversation and a rare networking opportunity between techies and biotechies. Hope to see you there on February 7.
